地塞米松预防危重患儿拔管后上气道阻塞:多中心双盲随机研究设计
本研究设计为多中心、前瞻性、双盲、随机、安慰剂对照的IV期临床试验,纳入1月龄至16岁、插管超过48小时的患儿,随机接受地塞米松0.25 mg/kg每6小时一次(拔管前6至12小时开始,共4剂)或安慰剂,主要目的是评估拔管后中重度上气道阻塞症状发生率的降低。
要点
- 地塞米松方案为0.25 mg/kg每6小时一次,拔管前6至12小时开始,共4剂。
- 纳入标准:1月龄至16岁,插管超过48小时。
- 主要结局:拔管后中重度上气道阻塞症状发生率的降低。
核心结论
- 研究结果将为拔管后气道阻塞的预防提供证据。
研究设计与样本
- 多中心、前瞻性、双盲、随机、安慰剂对照的IV期临床试验。
- 样本为1月龄至16岁、插管超过48小时的患儿,随机1:1分配。
- 排除有气道疾病或前7天内接受过类固醇的患者。
关键数值与推荐
- 地塞米松0.25 mg/kg每6小时一次,拔管前6至12小时开始,共4剂。
- 主要目标为评估拔管后中重度上气道阻塞症状发生率的降低。
- 次要目标包括再插管发生率、额外治疗使用及地塞米松副作用监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Post-extubation upper airway obstruction (UAO) is a frequent complication causing stridor and respiratory distress, which occasionally require reintubation, thereby increasing morbidity and mortality rates. Contradictory results have been obtained in studies assessing the effectiveness of steroids in preventing post-extubation UAO, and the available evidence is limited. We designed a multicentric randomized, placebo-controlled study to explore the effectiveness of dexamethasone in preventing post-extubation UAO in children. METHODS: A multicentric, prospective, double-blind, randomized, placebo-controlled, phase IV clinical trial has been designed. The sample will include pediatric patients who are between 1 month and 16 years of age and who have been intubated for more than 48 h. Patients who have airway disorders or who have received steroids within the previous seven days will be excluded. Patients will be randomly assigned to receive either placebo or a therapy with dexamethasone 0.25 mg/kg every 6 h to be started 6 to 12 h prior to extubation (to a total of four doses). Randomization will be performed at a 1:1 ratio. Follow-up of patients will be carried out for 48 h after extubation. The main objective of this study is to access the reduction in the incidence of moderate to severe UAO symptoms following extubation. Secondary objectives include assessing the decrease in the incidence of reintubation, evaluating the use of additional therapies for UAO, and monitoring potential side effects of dexamethasone. DISCUSSION: The results of this study will contribute to the existing evidence on prophylaxis for post-extubation airway obstruction. TRIAL REGISTRATION: EudraCT identifier: 2009-016596-30. Registered on May 11, 2010.
引用
- Manrique G, Butragueño-Laiseca L, González R, et al. Effectiveness of steroids versus placebo in preventing upper airway obstruction after extubation in critically ill children: rationale and design of a multicentric, double-blind, randomized study. Trials. 2020. PMID: 32307004. doi:10.1186/s13063-020-4218-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。